All Formulary decision guide articles
View all stories of the same content type.
-
Formulary decision guideSoprobec (beclometasone dipropionate) pMDI
This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-SOP-0130 December 2020 -
Formulary decision guide
Nutramigen* PURAMINO*
This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines inPractice.
RB-M-18261 October 2020 -
Formulary decision guide
Nutramigen* 1, 2 & 3 LGG®
This formulary decision guide was developed from content provided by Mead Johnson Nutrition in a format developed by Guidelines in Practice.
RB-M-18259 October 2020 -
Formulary decision guide
Doptelet®▼(Avatrombopag)
This formulary decision guide was developed from content provided by Swedish Orphan Biovitrum Ltd in a format developed by Guidelines in Practice.
View prescribing information and adverse events reporting
PP-9170 -
Formulary decision guide
Formulary decision guide: Saxenda® (liraglutide injection 3 mg)
This formulary decision guide has been commissioned by Novo Nordisk. Information intended for UK healthcare professionlas only.
Click here for the Prescribing Information and Adverse Events Reporting.
UK20SX00110
Date of preparation: October 2020 -
Formulary decision guide
Stalpex (salmeterol xinafoate/fluticasone propionate)
This formulary decision guide was developed from content provided by Glenmark Pharmaceuticals Europe Ltd in a format developed by Guidelines in Practice.
View prescribing information
PP-UK-STAL-0045 December 2020
